Device / Technology News

RSS

Zynx Health lauds definition of “meaningful use” of EHR technology

The U.S. Department of Health and Human Services' Centers for Medicare & Medicare Services (CMS) and the Office of the National Coordinator of Health Information Technology have announced that the definition of “meaningful use” will include the use of evidence-based order sets and clinical decision support at the point of care. This is good news because the peer-reviewed scientific literature has repeatedly shown that clinical decision support and evidence-based order sets can save patient lives and reduce overall healthcare costs.

5 Jan 2010

Significant opportunity for alternative ulcerative colitis biological therapy

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a biological therapy with a mechanism of action other than tumor necrosis factor alpha (TNF-alpha) inhibition for the treatment of moderate to severe ulcerative colitis, would earn a 25 percent patient share according to surveyed U.S. gastroenterologists. Similarly, in Europe, such an agent would also earn 25 percent patient share according to surveyed European gastroenterologists.

5 Jan 2010

ART publishes impressive data on its bioresorbable stent

Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company’s approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.

5 Jan 2010

Exergen TemporalScanner selected as one of 24 "Smartest Products of the Decade"

The Exergen TemporalScanner, a breakthrough innovation in medical thermometry, was selected last week as one of 24 "Smartest Products of the Decade" by Inc. magazine, which stated "These products revolutionized the way we spend our time -- technologically, culturally, and beyond."

5 Jan 2010

New chemoprevention therapy for skin cancer

People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.

5 Jan 2010

Irvine Scientific receives CE mark for its ART products

Irvine Scientific, a leader in Assisted Reproductive Technologies (ART) announced today that it has received CE mark for a full range of its media designed for ART: Complete P-1® Medium with DSS™, Blastocyst Freeze Media, Blastocyst Thaw Media, Embryo Freeze Media, Embryo Thaw Media, Complete Early Cleavage Medium® (ECM®) with DSS™ and Complete MultiBlast Medium® with DSS™, Sperm Washing Medium, Sperm Maintenance Medium w/ HSA, 7% PVP w/ HSA, 10% PVP w/ HSA.

5 Jan 2010

Boston Scientific commences enrollment in its TAXUS Liberte Stent System study

Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).

4 Jan 2010

BioElectronics set to market its Allay product in Chinese market

BioElectronics Corporation, the maker of inexpensive, disposable, drug-free, anti-inflammatory devices, today announces its entry into one most dynamic and fastest growing economies in the world, the People's Republic of China.

4 Jan 2010

Cardiogenesis submits an IDE for its PHOENIX System

Cardiogenesis Corporation, today announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.

4 Jan 2010

Bausch & Lomb launches Crystalens AO intraocular lens

Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide.

4 Jan 2010

Cepheid granted EUA for Xpert Flu A Panel test

Cepheid today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Xpert® Flu A Panel test.

4 Jan 2010

GeckoSystems to resume in home personal companion robot trials after Holidays

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that they have resumed their in home personal companion robot trials for elder care after pausing during the Holidays.

4 Jan 2010

Continua Health Alliance to showcase new end-to-end connected health solution at 2010 Consumer Electronics Show

Continua Health Alliance today announced the first end-to-end connected health solution based on the Continua architecture. Continua, the non-profit, open industry alliance of more than 220 leading healthcare and technology organizations, heralded the development as a significant milestone in the group’s mission to establish an ecosystem of interoperable personal connected health solutions.

4 Jan 2010

Cardima receives Shonin approval from the Japanese MHLW to market PATHFINDER catheters

Cardima, Inc., a medical device company focused on the diagnosis and treatment of atrial fibrillation (AF), has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to re-enter the Japanese market with its family of guidewire-based, multi-electrode PATHFINDER® diagnostic mapping catheters.

4 Jan 2010

WDI utilizes DXA analysis for fitness and weight management programs

Women's Digital Imaging of Ridgewood (WDI), has begun using Dual Energy X-ray Absorptiometry (DXA), a technology developed to screen for osteoporosis (bone loss), to measure body fat in patients who want a more accurate method of establishing goals and measuring results for weight management and fitness programs.

4 Jan 2010

Study shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism

A 5-year study of patients with severe traumatic brain injury conducted at Hennepin County Medical Center in Minneapolis shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability to recover from injury.

4 Jan 2010

EGS receives U.S. patent covering its SerosaFuse fastener and “over the wire” delivery system

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office has issued a key patent covering its SerosaFuse fastener and “over the wire” delivery system.

4 Jan 2010

Simulated Environment Concepts completes negotiations with Zen & O to manufacture 250 SpaCapsules

Simulated Environment Concepts, Inc., makers of the high pressurized dry water massage and relaxation station SpaCapsule, announced that it has completed negotiations with the French company Zen & O, securing a multi-million dollar deal to manufacture 250 SpaCapsules over the next four years.

4 Jan 2010

International Isotopes submits a license application for its uranium de-conversion and fluorine extraction project

International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.

3 Jan 2010

TENS therapy is not effective against chronic low-back pain

A new guideline issued by the American Academy of Neurology finds that transcutaneous electric nerve stimulation (TENS), a widely used pain therapy involving a portable device, is not recommended to treat chronic low-back pain that has persisted for three months or longer because research shows it is not effective.

31 Dec 2009